The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic Steatosis.

Raal, Frederick J

The Effects of Mipomersen on Inhibiting Hepatic VLDL Apolipoprotein B100 Synthesis and Propensity for Hepatic Steatosis. [electronic resource] - Clinical chemistry 08 2016 - 1052-3 p. digital

Publication Type: Journal Article; Comment

1530-8561

10.1373/clinchem.2016.255794 doi


Apolipoprotein B-100
Fatty Liver
Humans
Liver--drug effects
Oligonucleotides